Indefinite Delivery Contract 36C25022D0013

Award Date 10/20/21
Last Date to Order 10/19/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA-VHA VISN 17) awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,963,596.60 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide Roche Ventana reagents and consumables. This 5-year IDC serves as a vehicle for the VA to issue fixed-price delivery orders against, as needed, to support pathology and histology services at VA medical...
Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract has a potential value of $1,115,564.58 to provide reagents and supplies with no set-aside designation. Performance will take place through January 31, 2028. Under this contract, Roche Diagnostics was issued a $210,121.69 firm fixed price delivery order for reagents and supplies. The delivery...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 (VA - VHA VISN 9) awarded Roche Diagnostics Corporation a single-award indefinite delivery contract worth up to $815,294.66 to provide Roche reagents, diagnostic test kits, and associated laboratory equipment and supplies. This contract, which has a base period of one year and four option years through September 2025, will allow VISN 9 to efficiently order essential medical consumables and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation an indefinite delivery contract for reagents. The IDV has a potential value of $700,000 and a period of performance through September 1, 2027. No set-aside was used. Under the IDV, Roche Diagnostics has received multiple delivery orders for reagents to support medical testing programs across VISN 1 facilities. Delivery orders ranged in value from...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products, laboratory instruments, and associated medical equipment and supplies. The BPA, valued at up to $962,399.40, enables the VA's Veterans Integrated Service Network 17 to acquire Roche's Ventana Benchmark Ultra reagents, equipment, and supplies to support diagnostic pathology...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a single-award indefinite delivery contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory instruments, to provide reagents, supplies, and consumables for Roche-manufactured Cobas 6800/8800 laboratory instruments. The $1,170,000 IDC has a 5-year ordering period ending on September 30, 2026. Under this IDC, the VA VHA has awarded multiple delivery orders to Roche...
  • 36C25022D0013
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award indefinite delivery contract to Roche Diagnostics Corporation for Roche Ventana reagents. The contract includes three firm fixed price delivery orders totaling $2,275,000, $455,000.04, and $2,251,572.95 respectively, with a period of performance from October 2021 through October 2026. Place of performance is in Castleton, Indiana.

The reagents supplied under this contract support the VA-VHA's laboratory diagnostic testing programs. Specifically, Roche will provide its Ventana reagents, which are used in immunohistochemistry and in situ hybridization assays performed on tissue samples. These diagnostic assays aid the VA-VHA network in cancer diagnosis and prognosis determination for the veterans it serves. The original special notice indicated the contracting office's intent to award a sole-source indefinite delivery, indefinite quantity contract directly to Roche Diagnostics as the proprietary manufacturer and domestic distributor of reagents for the Ventana Benchmark system currently used by the VA Medical Center in Cincinnati, Ohio.

Generated 1/4/24, 11:43 PM